Moderna, Inc. (BVMF:M1RN34)

Moderna Statistics

Total Valuation

Moderna has a market cap or net worth of BRL 108.56 billion. The enterprise value is 73.51 billion.

Market Cap	108.56B
Enterprise Value	73.51B

Important Dates

The last earnings date was Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+1.30%
Shares Change (QoQ)	+0.51%
Owned by Insiders (%)	6.64%
Owned by Institutions (%)	80.82%
Float	368.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.14
PB Ratio	2.28
P/TBV Ratio	2.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.73
EV / Sales	7.37
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.46

Financial Position

The company has a current ratio of 3.29, with a Debt / Equity ratio of 0.15.

Current Ratio	3.29
Quick Ratio	3.06
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	-0.63
Interest Coverage	-307.40

Financial Efficiency

Return on equity (ROE) is -28.87% and return on invested capital (ROIC) is -63.28%.

Return on Equity (ROE)	-28.87%
Return on Assets (ROA)	-14.51%
Return on Invested Capital (ROIC)	-63.28%
Return on Capital Employed (ROCE)	-29.70%
Weighted Average Cost of Capital (WACC)	10.93%
Revenue Per Employee	2.28M
Profits Per Employee	-3.31M
Employee Count	4,700
Asset Turnover	0.15
Inventory Turnover	29.63

Taxes

In the past 12 months, Moderna has paid 297.43 million in taxes.

Income Tax	297.43M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +35.16% in the last 52 weeks. The beta is 1.34, so Moderna's price volatility has been higher than the market average.

Beta (5Y)	1.34
52-Week Price Change	+35.16%
50-Day Moving Average	10.69
200-Day Moving Average	8.19
Relative Strength Index (RSI)	68.16
Average Volume (20 Days)	59,748

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	6.12

Income Statement

In the last 12 months, Moderna had revenue of BRL 10.71 billion and -15.54 billion in losses. Loss per share was -39.96.

Revenue	10.71B
Gross Profit	-11.32B
Operating Income	-16.93B
Pretax Income	-15.25B
Net Income	-15.54B
EBITDA	-15.75B
EBIT	-16.93B
Loss Per Share	-39.96

Balance Sheet

The company has 31.94 billion in cash and 7.19 billion in debt, with a net cash position of 37.62 billion.

Cash & Cash Equivalents	31.94B
Total Debt	7.19B
Net Cash	37.62B
Net Cash Per Share	n/a
Equity (Book Value)	47.64B
Book Value Per Share	120.92
Working Capital	25.10B

Cash Flow

In the last 12 months, operating cash flow was -10.32 billion and capital expenditures -1.06 billion, giving a free cash flow of -11.37 billion.

Operating Cash Flow	-10.32B
Capital Expenditures	-1.06B
Free Cash Flow	-11.37B
FCF Per Share	n/a

Margins

Gross margin is -105.76%, with operating and profit margins of -158.13% and -145.16%.

Gross Margin	-105.76%
Operating Margin	-158.13%
Pretax Margin	-142.39%
Profit Margin	-145.16%
EBITDA Margin	-147.07%
EBIT Margin	-158.13%
FCF Margin	n/a

Dividends & Yields

Moderna does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.30%
Shareholder Yield	-1.30%
Earnings Yield	-14.32%
FCF Yield	-10.48%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 21, 2022. It was a forward split with a ratio of 2.

Last Split Date	Nov 21, 2022
Split Type	Forward
Split Ratio	2

Scores

Moderna has an Altman Z-Score of 2.44 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.44
Piotroski F-Score	1